The Form 4 filing lists the sale and filing dates as November 17, 2026. Form 4 reports changes in a company insider's share ownership.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-17 |
| Date of Latest Transaction | 2026-11-17 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 62,000 |
| Price | $8.45 |
| Total Transaction Value | $523,900.00 |
| Insider | |
| Ticker Symbol | MGTX |
| Company | MeiraGTx Holdings plc |
| Insider Name | Forbes Alexandria |
| Insider Title | PRESIDENT & CEO |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 1,239,595 |
| Position Size Change | 4.76% |
| Filing | |
| Filing Date | 2026-11-17 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share sale, recorded under transaction code S. Alexandria Forbes, MeiraGTx Holdings plc's president and CEO, sold 62,000 MGTX shares in one transaction.
What was the average price of the transaction?
The reported average sale price was $8.45 per share.
How did this transaction affect the insider's holdings?
The sale reduced reported holdings by 62,000 shares, leaving 1,239,595 shares owned afterward. The shares sold made up 4.76% of the shares owned before the sale.
What's the total transaction value?
The total value was $523,900.00 for the single reported sale.
Are there any special circumstances around this transaction?
The transaction information identifies a reference to a Rule 10b5-1 trading plan. These plans set trading instructions in advance.
The footnote text is unavailable, so it is unclear whether the reference covers this specific sale or the filing as a whole. The plan's start date, trading schedule and other terms are unknown. A plan reference alone does not establish that the sale met the rule's legal requirements or explain the reason for the sale.
Source: SEC Form 4 filing.
For research purposes only; not investment advice.